0

Encephalopathy Collection
 1-20 of 88 Articles
Articles |  7 September 2010
Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients With Cirrhosis: A Cohort Study
Manuel Romero-Gómez, MD, PhD; María Jover, PhD; José A. Del Campo, PhD; et al.
Ann Intern Med. 2010;153(5):281-288. doi:10.7326/0003-4819-153-5-201009070-00002
Editorials |  7 September 2010
Hepatic Encephalopathy in Our Genes?
Jan Albrecht, PhD
Ann Intern Med. 2010;153(5):335-336. doi:10.7326/0003-4819-153-5-201009070-00008
Reviews |  20 March 2007
Narrative Review: Fabry Disease
Joe T.R. Clarke, MD, PhD
Ann Intern Med. 2007;146(6):425-433. doi:10.7326/0003-4819-146-6-200703200-00007
Articles |  16 January 2007 FREE
Agalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial
Maryam Banikazemi, MD; Jan Bultas, MD, PhD; Stephen Waldek, MB, BCh; et al.
Ann Intern Med. 2007;146(2):77-86. doi:10.7326/0003-4819-146-2-200701160-00148
Editorials |  16 January 2007 FREE
Enzyme Replacement in Fabry Disease: The Essence Is in the Kidney
Raphael Schiffmann, MD
Ann Intern Med. 2007;146(2):142-144. doi:10.7326/0003-4819-146-2-200701160-00147
Current Clinical Issues |  15 November 2005
Why Prion Diseases Are a Mystery, and Why They Matter
Jennifer Fisher Wilson
Ann Intern Med. 2005;143(10):773-776. doi:10.7326/0003-4819-143-10-200511150-00037
Brief Communications |  1 March 1998
Severe Hyperbilirubinemia after Creation of Transjugular Intrahepatic Portosystemic Shunts: Natural History and Predictors of Outcome
Smita S. Rouillard, MD; Nathan M. Bass, MD, PhD; John P. Roberts, MD; et al.
Ann Intern Med. 1998;128(5):374-377. doi:10.7326/0003-4819-128-5-199803010-00006
Articles |  1 July 1997
Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction
Theresia Maier-Dobersberger, MD; Peter Ferenci, MD; Claudia Polli; et al.
Ann Intern Med. 1997;127(1):21-26. doi:10.7326/0003-4819-127-1-199707010-00004
Editorials |  1 July 1997
Genetic Heterogeneity in Wilson Disease: Lessons from Rare Alleles
Reed Edwin Pyeritz, MD, PhD
Ann Intern Med. 1997;127(1):70-72. doi:10.7326/0003-4819-127-1-199707010-00011
Articles |  1 June 1997
Transjugular Intrahepatic Portosystemic Shunts Compared with Endoscopic Sclerotherapy for the Prevention of Recurrent Variceal Hemorrhage: A Randomized, Controlled Trial
Arun J. Sanyal, MD; Arthur M. Freedman, MD; Velimir A. Luketic, MD; et al.
Ann Intern Med. 1997;126(11):849-857. doi:10.7326/0003-4819-126-11-199706010-00001
Editorials |  1 June 1997
Transjugular Intrahepatic Portosystemic Shunts Versus Sclerotherapy: A Discussion of Discordant Results
Harold O. Conn, MD
Ann Intern Med. 1997;126(11):907-910. doi:10.7326/0003-4819-126-11-199706010-00010
Brief Communications |  1 December 1996
Pulmonary Hypertension Developing after Alglucerase Therapy in Two Patients with Type 1 Gaucher Disease Complicated by the Hepatopulmonary Syndrome
Arthur Dawson, MD; Darlene J. Elias, MD; David Rubenson, MD; et al.
Ann Intern Med. 1996;125(11):901-904. doi:10.7326/0003-4819-125-11-199612010-00005
Articles |  1 January 1995
Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant Sources
Gregory A. Grabowski, MD; Norman W. Barton, MD, PhD; Gregory Pastores, MD; et al.
Ann Intern Med. 1995;122(1):33-39. doi:10.7326/0003-4819-122-1-199501010-00005
Brief Communications |  1 August 1994
Glucocerebrosidase Treatment of Type I Gaucher Disease with Severe Pulmonary Involvement
Michael Pelini, MD; Douglas Boice*, MD; Kevin O'Neil, MD; et al.
Ann Intern Med. 1994;121(3):196-197. doi:10.7326/0003-4819-121-3-199408010-00006
Articles |  1 December 1992
Postoperative Hyponatremic Encephalopathy in Menstruant Women
J. Carlos Ayus, MD; James M. Wheeler, MD, MPH; Allen I. Arieff, MD
Ann Intern Med. 1992;117(11):891-897. doi:10.7326/0003-4819-117-11-891
Brief Reports |  1 August 1992
Fabry Disease: An Unusual Cause of Severe Coronary Disease in a Young Man
Edward A. Fisher, MD; Robert J. Desnick, PhD, MD; Ronald E. Gordon, PhD; et al.
Ann Intern Med. 1992;117(3):221-223. doi:10.7326/0003-4819-117-3-221
Reviews |  1 November 1991
Wilson Disease: Clinical Presentation, Treatment, and Survival
Wolfgang Stremmel, MD; Karl-Wilhelm Meyerrose, MD; Claus Niederau, MD; et al.
Ann Intern Med. 1991;115(9):720-726. doi:10.7326/0003-4819-115-9-720
Articles |  15 July 1990
The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion: Clinical Features in 20 Patients and Aspects of Pathophysiology
Richard W. Martin, MD; Joseph Duffy, MD; Andrew G. Engel, MD; et al.
Ann Intern Med. 1990;113(2):124-134. doi:10.7326/0003-4819-113-2-124
Articles |  1 April 1987
Extracorporeal Enzyme Reactors for Depletion of Phenylalanine in Phenylketonuria
CLARA M. AMBRUS, M.D., Ph.D.; SIDNEY ANTHONE, M.D.; CSABA HORVATH, Ph.D.; et al.
Ann Intern Med. 1987;106(4):531-537. doi:10.7326/0003-4819-106-4-531
Brief Communications |  1 April 1987
Ornithine Transcarbamylase Deficiency: Adult Onset of Severe Symptoms
JAMES M. GILCHRIST, M.D.; ROSALIND A. COLEMAN, M.D.
Ann Intern Med. 1987;106(4):556-558. doi:10.7326/0003-4819-106-4-556
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)